NO20022654D0 - Amycomycin, en fremgangsmåte for dens fremstilling og dens anvendelse som farmasöytisk middel - Google Patents

Amycomycin, en fremgangsmåte for dens fremstilling og dens anvendelse som farmasöytisk middel

Info

Publication number
NO20022654D0
NO20022654D0 NO20022654A NO20022654A NO20022654D0 NO 20022654 D0 NO20022654 D0 NO 20022654D0 NO 20022654 A NO20022654 A NO 20022654A NO 20022654 A NO20022654 A NO 20022654A NO 20022654 D0 NO20022654 D0 NO 20022654D0
Authority
NO
Norway
Prior art keywords
amycomycin
preparation
pharmaceutical agent
pharmaceutical
stereoisomeric
Prior art date
Application number
NO20022654A
Other languages
English (en)
Other versions
NO322565B1 (no
NO20022654L (no
Inventor
Cordula Hopmann
Michael Kurz
Heinrich Decker
Dominique Le Beller
Jozsef Aszodi
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20022654D0 publication Critical patent/NO20022654D0/no
Publication of NO20022654L publication Critical patent/NO20022654L/no
Publication of NO322565B1 publication Critical patent/NO322565B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20022654A 1999-12-08 2002-06-05 Amycomycin, en fremgangsmate for dens fremstilling og dens anvendelse som farmasoytisk middel, og farmasoytisk sammensetning NO322565B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical
PCT/EP2000/011752 WO2001042210A1 (en) 1999-12-08 2000-11-25 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (3)

Publication Number Publication Date
NO20022654D0 true NO20022654D0 (no) 2002-06-05
NO20022654L NO20022654L (no) 2002-06-05
NO322565B1 NO322565B1 (no) 2006-10-23

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022654A NO322565B1 (no) 1999-12-08 2002-06-05 Amycomycin, en fremgangsmate for dens fremstilling og dens anvendelse som farmasoytisk middel, og farmasoytisk sammensetning

Country Status (28)

Country Link
US (1) US6642391B2 (no)
EP (2) EP1106604A1 (no)
JP (1) JP4750993B2 (no)
KR (1) KR100728514B1 (no)
CN (1) CN1217929C (no)
AT (1) ATE298744T1 (no)
AU (1) AU781398B2 (no)
BR (1) BR0016223A (no)
CA (1) CA2393518C (no)
CZ (1) CZ294370B6 (no)
DE (1) DE60021109T2 (no)
DK (1) DK1237866T3 (no)
EE (1) EE05219B1 (no)
ES (1) ES2243332T3 (no)
HK (1) HK1048998A1 (no)
HR (1) HRP20020497B1 (no)
HU (1) HU225194B1 (no)
IL (2) IL149904A0 (no)
ME (1) MEP28508A (no)
NO (1) NO322565B1 (no)
PL (1) PL201809B1 (no)
PT (1) PT1237866E (no)
RS (1) RS50288B (no)
RU (1) RU2261916C2 (no)
SI (1) SI1237866T1 (no)
SK (1) SK286776B6 (no)
WO (1) WO2001042210A1 (no)
ZA (1) ZA200204420B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、ｍｉ７１０−５１ｆ６物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質ｍｉ４８１−４２ｆ４−ａ及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンｂおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンａおよびｂとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
WO2001042210A1 (en) 2001-06-14
CZ294370B6 (cs) 2004-12-15
EP1237866B1 (en) 2005-06-29
CZ20021891A3 (cs) 2002-08-14
CN1217929C (zh) 2005-09-07
DE60021109T2 (de) 2006-05-04
HUP0203593A2 (hu) 2003-02-28
AU2001901A (en) 2001-06-18
YU13102A (sh) 2005-06-10
HUP0203593A3 (en) 2003-12-29
US20010018450A1 (en) 2001-08-30
RU2002118116A (ru) 2004-02-27
CA2393518C (en) 2009-01-20
HU225194B1 (en) 2006-08-28
NO322565B1 (no) 2006-10-23
SI1237866T1 (en) 2005-10-31
EE05219B1 (et) 2009-10-15
JP4750993B2 (ja) 2011-08-17
RU2261916C2 (ru) 2005-10-10
ZA200204420B (en) 2003-09-03
ME00182B (me) 2010-10-10
IL149904A (en) 2007-10-31
SK7872002A3 (en) 2002-11-06
DK1237866T3 (da) 2005-10-10
SK286776B6 (sk) 2009-05-07
HRP20020497B1 (en) 2006-04-30
US6642391B2 (en) 2003-11-04
HK1048998A1 (en) 2003-04-25
CN1377341A (zh) 2002-10-30
ES2243332T3 (es) 2005-12-01
MEP28508A (en) 2010-10-10
IL149904A0 (en) 2002-11-10
BR0016223A (pt) 2002-09-10
EE200200280A (et) 2003-06-16
CA2393518A1 (en) 2001-06-14
NO20022654L (no) 2002-06-05
AU781398B2 (en) 2005-05-19
DE60021109D1 (de) 2005-08-04
EP1237866A1 (en) 2002-09-11
HRP20020497A2 (en) 2004-08-31
PT1237866E (pt) 2005-10-31
PL201809B1 (pl) 2009-05-29
RS50288B (sr) 2009-09-08
KR20020063205A (ko) 2002-08-01
ATE298744T1 (de) 2005-07-15
PL355627A1 (en) 2004-05-04
KR100728514B1 (ko) 2007-06-15
JP2003516389A (ja) 2003-05-13
EP1106604A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
AU1025795A (en) Prolineamide derivatives
DK1274698T3 (da) Percyquinnin, en fremgangsmåde til dets fremstilling og dets anvendelse som et farmaceutisk middel
NO983074L (no) Karbamoyloksyderivater av mutilin og deres anvendelse som antibakterielle midler
AU7001996A (en) Novel derivatives of cyclodepsipeptide PF1022 substance
FI101227B1 (fi) Menetelmä farmaseuttisesti aktiivisten 4-desoksi-4-epipodofyllotoksiinijohdannaisten valmistamiseksi
NO20022654L (no) Amycomycin, en fremgangsmåte for dens fremstilling og dens anvendelse som farmasöytisk middel
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
DE69914880D1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
EP1241167A4 (en) DERIVATIVES OF 3-ETHYL-, 3-PROPYL-, OR 3-BUTYL-CHROMANE AND -THIOCHROMANE
HU9803043D0 (en) Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-azo-9a-homoerythromycin-a
EP1241166A4 (en) 3-MEHTYL CHROMAN AND THIOCHROME DERIVATIVES
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
AR026715A1 (es) Amicomicina, un proceso para su produccion y su uso como un producto farmaceutico.
NO933324L (no) Isoindoler med kardiovaskulaer aktivitet

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees